Tata 1mg-Style Machine Coding Round: Format, Tips & Practice Problems
Written and reviewed by Sahil Srivastav
Diagnostics is a fulfilment pipeline with a physical sample at its centre. A booking becomes a home collection in a slot, the sample is collected and transported, the lab processes each test on its own timeline, and results are released — sometimes one test at a time, sometimes only when a panel is complete. Machine coding rounds in the style of Tata 1mg use that sample-to-report chain.
What makes it a good interview domain is that one booking fans out into independently progressing units, and packages complicate it further: a health package contains panels which contain tests, and a test appearing in two purchased packages must be collected and billed once. This page covers the format, the evaluation criteria, and Gronex repositories with the same mechanics.
What a Tata 1mg-style machine coding round looks like
A typical statement is a diagnostics booking service: choose tests or packages, expand them into the actual test set with duplicates removed, book a home-collection slot with phlebotomist capacity per area, then track each test through collected, in-lab, resulted, and released. Reporting rules are supplied — release individually, or hold a panel until all its tests are resulted.
Package expansion is the first graded piece and it is more subtle than it reads. Two packages overlapping on three tests must produce one collection and one billing line per test, while the customer-facing view still shows both packages. The clean model separates purchased items from resolved tests with a link between them; a flattened list either double-collects or loses the package structure, and the reviewer checks both directions.
Then the per-test lifecycle brings partial progress. Nine of ten tests resulted and one rerun requested is the normal state of a real booking, so the booking status must be derived from its tests, and release rules must be evaluated per panel. Rescheduling a collection after partial collection, and a sample rejected at the lab requiring recollection, are the two probes that separate a modelled pipeline from a status field.
How you’re evaluated
Package expansion with dedupe
Purchased packages resolved into a unique test set, billed and collected once, while the package view is preserved.
Per-test lifecycle
Each test progressing independently, with booking status derived from its tests rather than stored alongside them.
Release rules per panel
Individual or hold-until-complete release implemented as a policy on the panel, not scattered through the result handler.
Slot capacity with release
Collection slots constrained per area and per collector, claimed atomically and released on cancellation or reschedule.
Common mistakes that fail this round
- Flattening packages into a test list, losing the ability to show or refund a package.
- Failing to deduplicate overlapping tests, so the customer is billed and pricked twice.
- Keeping a single status on the booking, which cannot express nine resulted and one rerun.
- Handling recollection by resetting the booking, destroying the history of the rejected sample.
- Booking collection slots with a read-then-increment, over-allocating a collector’s capacity.
Quick tips for the room
- Separate purchased items from resolved tests and link them.
- Deduplicate the test set before pricing or collection.
- Give each test its own status; derive the booking status.
- Make slot claiming one atomic operation with a release path.
How to prepare
Build the expansion step as a pure function from purchased items to a unique test set with provenance links, then give each test its own lifecycle and derive the booking status. Add the panel release policy last. If the statement is pharmacy-focused instead, the same discipline applies to line-level fulfilment across pharmacies.
The repositories below cover the pieces: the shared-calendar problem is collection-slot claiming under contention, the order tracker is the per-unit state machine, the task dependency problem is the gated lab progression, the exam grading engine is per-item results aggregated under release rules, and the free seat-reservation problem is the capacity baseline.
Practice problems in the Tata 1mg-style round format
Each is a real backend repository with a failing test suite — the same working-code standard the round applies. Open the brief and read the full problem, no signup required.
Shared Calendar Slot Booking
Collection-slot booking under contention: capacity per collector, overlap rules, no double-booking.
Open the challenge →Order Status Tracker
The per-unit lifecycle: legal transitions, cancellation rules, and complete status history.
Open the challenge →Task Dependency Manager
Gated progression with prerequisites and deterministic ordering — the lab pipeline in abstract form.
Open the challenge →Attempt & Grading Engine
Per-item results aggregated under release rules — the same shape as panel-gated report release.
Open the challenge →Seat Reservation System
Capacity claiming at its simplest: reserve, cancel, list availability deterministically. Free to try.
Open the challenge →FAQ
Are these actual Tata 1mg interview questions?
No. They are Gronex originals in the style of diagnostics and e-pharmacy rounds — the kind of problem asked in rounds like Tata 1mg’s. Gronex is not affiliated with Tata 1mg.
Why is package expansion the graded part?
Because it is where a plausible design silently overcharges. Deduplicating tests while preserving package provenance requires two linked structures, and candidates who use one always lose something the reviewer asks for.
Do I need to model lab equipment or turnaround times?
Only as data on the test — an expected turnaround is enough to make release timing meaningful. The graded surface is the per-test lifecycle and the release policy, not lab operations.
What is the most commonly missed case?
Sample rejection and recollection. It requires a test to go backwards to a re-collection state while keeping the history of the failed attempt, which a single mutable status field cannot represent.
Related
Gronex is not affiliated with, endorsed by, or sponsored by Tata 1mg. All company names and trademarks belong to their respective owners. The problems on this page are Gronex originals written in the style of such interview rounds — not actual interview questions from Tata 1mg.